Today, NanoEcho has published its Annual Report for 2024, a year of significant progress for NanoEcho! We have taken the crucial step from development to clinical phase, while also becoming a publicly listed company – milestones that strengthen our path towards commercialisation. In 2025, we will continue our clinical programme and take important steps towards regulatory approval.
Some of the highlights of the year:
– Completed product development
– Launch of our first clinical study
– ISO 13485 certification
– Strategic business agreement with SPL Medical
– Listing on Nasdaq First North
Read the full report here! (in Swedish)
Don’t miss when CEO Linda Persson reviews the year in the video below!
